Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 608 entries
Sorted by: Best Match Show Resources per page
[Screening].

Enfermedades infecciosas y microbiologia clinica

Gili M, Donado J, Hernández I.
PMID: 2098135
Enferm Infecc Microbiol Clin. 1990 Feb;8(2):108-15.

No abstract available.

Cite
Gili M, Donado J, Hernández I. Cribados (screening). [Screening]. Enferm Infecc Microbiol Clin. 1990;8(2):108-15
Gili, M., Donado, J., & Hernández, I. (1990). Cribados (screening). [Screening]. Enfermedades infecciosas y microbiologia clinica, 8(2), 108-15.
Gili, M, et al. "Cribados (screening)." [Screening]. Enfermedades infecciosas y microbiologia clinica vol. 8,2 (1990): 108-15.
Gili M, Donado J, Hernández I. Cribados (screening). [Screening]. Enferm Infecc Microbiol Clin. 1990 Feb;8(2):108-15. Spanish. PMID: 2098135.
Copy Download .nbib Format: NLM
[Types of epidemiological study. Cohort studies].

Enfermedades infecciosas y microbiologia clinica

Gili M, Ruiz-Canela MP, Briones E.
PMID: 2490481
Enferm Infecc Microbiol Clin. 1989 Nov;7(9):507-13.

No abstract available.

Cite
Gili M, Ruiz-Canela MP, Briones E. Tipos de estudios epidemiológicos. Los estudios de cohortes. [Types of epidemiological study. Cohort studies]. Enferm Infecc Microbiol Clin. 1989;7(9):507-13
Gili, M., Ruiz-Canela, M. P., & Briones, E. (1989). Tipos de estudios epidemiológicos. Los estudios de cohortes. [Types of epidemiological study. Cohort studies]. Enfermedades infecciosas y microbiologia clinica, 7(9), 507-13.
Gili, M, et al. "Tipos de estudios epidemiológicos. Los estudios de cohortes." [Types of epidemiological study. Cohort studies]. Enfermedades infecciosas y microbiologia clinica vol. 7,9 (1989): 507-13.
Gili M, Ruiz-Canela MP, Briones E. Tipos de estudios epidemiológicos. Los estudios de cohortes. [Types of epidemiological study. Cohort studies]. Enferm Infecc Microbiol Clin. 1989 Nov;7(9):507-13. Spanish. PMID: 2490481.
Copy Download .nbib Format: NLM
Geoffrey Munro Gill.

BMJ (Clinical research ed.)

Gill M, Fouin P.
PMID: 28455427
BMJ. 2017 Apr 28;357:j2038. doi: 10.1136/bmj.j2038.

No abstract available.

Cite
Gill M, Fouin P. Geoffrey Munro Gill. BMJ. 2017;357:j2038doi: 10.1136/bmj.j2038.
Gill, M., & Fouin, P. (2017). Geoffrey Munro Gill. BMJ (Clinical research ed.), 357j2038. https://doi.org/10.1136/bmj.j2038
Gill, Margaret, and Fouin, Pierre. "Geoffrey Munro Gill." BMJ (Clinical research ed.) vol. 357 (2017): j2038. doi: https://doi.org/10.1136/bmj.j2038
Gill M, Fouin P. Geoffrey Munro Gill. BMJ. 2017 Apr 28;357:j2038. doi: 10.1136/bmj.j2038. PMID: 28455427.
Copy Download .nbib Format: NLM
Comparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute Urticaria.

Journal of clinical and diagnostic research : JCDR

Goyal V, Gupta A, Gupta O, Lal D, Gill M.
PMID: 28511488
J Clin Diagn Res. 2017 Mar;11(3):WC06-WC09. doi: 10.7860/JCDR/2017/23961.9550. Epub 2017 Mar 01.

INTRODUCTION: Acute and chronic urticaria can result in severely impaired quality of life from pruritus and associated sleep lessness, as well as anxiety and depression. Various treatment modalities are available out of which second generation non sedating H1 antihistamines...

Cite
Goyal V, Gupta A, Gupta O, et al. Comparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute Urticaria. J Clin Diagn Res. 2017;11(3):WC06-WC09doi: 10.7860/JCDR/2017/23961.9550.
Goyal, V., Gupta, A., Gupta, O., Lal, D., & Gill, M. (2017). Comparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute Urticaria. Journal of clinical and diagnostic research : JCDR, 11(3), WC06-WC09. https://doi.org/10.7860/JCDR/2017/23961.9550
Goyal, Vippan, et al. "Comparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute Urticaria." Journal of clinical and diagnostic research : JCDR vol. 11,3 (2017): WC06-WC09. doi: https://doi.org/10.7860/JCDR/2017/23961.9550
Goyal V, Gupta A, Gupta O, Lal D, Gill M. Comparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute Urticaria. J Clin Diagn Res. 2017 Mar;11(3):WC06-WC09. doi: 10.7860/JCDR/2017/23961.9550. Epub 2017 Mar 01. PMID: 28511488; PMCID: PMC5427414.
Copy Download .nbib Format: NLM
Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study.

Annals of intensive care

Póvoa P, Martin-Loeches I, Ramirez P, Bos LD, Esperatti M, Silvestre J, Gili G, Goma G, Berlanga E, Espasa M, Gonçalves E, Torres A, Artigas A.
PMID: 27076187
Ann Intensive Care. 2016 Dec;6(1):32. doi: 10.1186/s13613-016-0134-8. Epub 2016 Apr 14.

BACKGROUND: Prediction of diagnosis of ventilator-associated pneumonia (VAP) remains difficult. Our aim was to assess the value of biomarker kinetics in VAP prediction.METHODS: We performed a prospective, multicenter, observational study to evaluate predictive accuracy of biomarker kinetics, namely C-reactive...

Cite
Póvoa P, Martin-Loeches I, Ramirez P, et al. Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study. Ann Intensive Care. 2016;6(1):32doi: 10.1186/s13613-016-0134-8.
Póvoa, P., Martin-Loeches, I., Ramirez, P., Bos, L. D., Esperatti, M., Silvestre, J., Gili, G., Goma, G., Berlanga, E., Espasa, M., Gonçalves, E., Torres, A., & Artigas, A. (2016). Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study. Annals of intensive care, 6(1), 32. https://doi.org/10.1186/s13613-016-0134-8
Póvoa, Pedro, et al. "Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study." Annals of intensive care vol. 6,1 (2016): 32. doi: https://doi.org/10.1186/s13613-016-0134-8
Póvoa P, Martin-Loeches I, Ramirez P, Bos LD, Esperatti M, Silvestre J, Gili G, Goma G, Berlanga E, Espasa M, Gonçalves E, Torres A, Artigas A. Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study. Ann Intensive Care. 2016 Dec;6(1):32. doi: 10.1186/s13613-016-0134-8. Epub 2016 Apr 14. PMID: 27076187; PMCID: PMC4830786.
Copy Download .nbib Format: NLM
Polarization properties of second-harmonic generation in AlGaAs optical nanoantennas.

Optics letters

Ghirardini L, Carletti L, Gili V, Pellegrini G, Duò L, Finazzi M, Rocco D, Locatelli A, De Angelis C, Favero I, Ravaro M, Leo G, Lemaître A, Celebrano M.
PMID: 28146527
Opt Lett. 2017 Feb 01;42(3):559-562. doi: 10.1364/OL.42.000559.

Manipulating light at the nanoscale by means of dielectric nanoantennas recently received renewed attention thanks to the development of key enabling fabrication tools in semiconductor technology, combined with the extremely low losses exhibited by dielectrics in the optical regime....

Cite
Ghirardini L, Carletti L, Gili V, et al. Polarization properties of second-harmonic generation in AlGaAs optical nanoantennas. Opt Lett. 2017;42(3):559-562doi: 10.1364/OL.42.000559.
Ghirardini, L., Carletti, L., Gili, V., Pellegrini, G., Duò, L., Finazzi, M., Rocco, D., Locatelli, A., De Angelis, C., Favero, I., Ravaro, M., Leo, G., Lemaître, A., & Celebrano, M. (2017). Polarization properties of second-harmonic generation in AlGaAs optical nanoantennas. Optics letters, 42(3), 559-562. https://doi.org/10.1364/OL.42.000559
Ghirardini, L, et al. "Polarization properties of second-harmonic generation in AlGaAs optical nanoantennas." Optics letters vol. 42,3 (2017): 559-562. doi: https://doi.org/10.1364/OL.42.000559
Ghirardini L, Carletti L, Gili V, Pellegrini G, Duò L, Finazzi M, Rocco D, Locatelli A, De Angelis C, Favero I, Ravaro M, Leo G, Lemaître A, Celebrano M. Polarization properties of second-harmonic generation in AlGaAs optical nanoantennas. Opt Lett. 2017 Feb 01;42(3):559-562. doi: 10.1364/OL.42.000559. PMID: 28146527.
Copy Download .nbib Format: NLM
Olanzapine in the treatment of depression with psychotic features: A prospective open-label study.

International journal of psychiatry in clinical practice

Adli M, Wiethoff K, Baethge C, Pfennig A, Stamm T, Bauer M.
PMID: 24931659
Int J Psychiatry Clin Pract. 2008;12(3):202-9. doi: 10.1080/13651500801911144.

Objective. Depression with psychotic features is a severe subtype of major depression associated with the presence of delusions, hallucinations and specific neurobiological features. Despite clinical consensus and guideline recommendations, data comparing the efficacy of combining antipsychotics with antidepressants compared...

Cite
Adli M, Wiethoff K, Baethge C, et al. Olanzapine in the treatment of depression with psychotic features: A prospective open-label study. Int J Psychiatry Clin Pract. 2008;12(3):202-9doi: 10.1080/13651500801911144.
Adli, M., Wiethoff, K., Baethge, C., Pfennig, A., Stamm, T., & Bauer, M. (2008). Olanzapine in the treatment of depression with psychotic features: A prospective open-label study. International journal of psychiatry in clinical practice, 12(3), 202-9. https://doi.org/10.1080/13651500801911144
Adli, Mazda, et al. "Olanzapine in the treatment of depression with psychotic features: A prospective open-label study." International journal of psychiatry in clinical practice vol. 12,3 (2008): 202-9. doi: https://doi.org/10.1080/13651500801911144
Adli M, Wiethoff K, Baethge C, Pfennig A, Stamm T, Bauer M. Olanzapine in the treatment of depression with psychotic features: A prospective open-label study. Int J Psychiatry Clin Pract. 2008;12(3):202-9. doi: 10.1080/13651500801911144. PMID: 24931659.
Copy Download .nbib Format: NLM
Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study.

Frontiers in pediatrics

Pini G, Scusa MF, Benincasa A, Bottiglioni I, Congiu L, Vadhatpour C, Romanelli AM, Gemo I, Puccetti C, McNamara R, O'Leary S, Corvin A, Gill M, Tropea D.
PMID: 24918098
Front Pediatr. 2014 Jun 03;2:52. doi: 10.3389/fped.2014.00052. eCollection 2014.

Rett syndrome (RTT) is a devastating neurodevelopmental disorder that has no cure. Patients show regression of acquired skills, motor, and speech impairment, cardio-respiratory distress, microcephaly, and stereotyped hand movements. The majority of RTT patients display mutations in the gene...

Cite
Pini G, Scusa MF, Benincasa A, et al. Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study. Front Pediatr. 2014;2:52doi: 10.3389/fped.2014.00052.
Pini, G., Scusa, M. F., Benincasa, A., Bottiglioni, I., Congiu, L., Vadhatpour, C., Romanelli, A. M., Gemo, I., Puccetti, C., McNamara, R., O'Leary, S., Corvin, A., Gill, M., & Tropea, D. (2014). Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study. Frontiers in pediatrics, 252. https://doi.org/10.3389/fped.2014.00052
Pini, Giorgio, et al. "Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study." Frontiers in pediatrics vol. 2 (2014): 52. doi: https://doi.org/10.3389/fped.2014.00052
Pini G, Scusa MF, Benincasa A, Bottiglioni I, Congiu L, Vadhatpour C, Romanelli AM, Gemo I, Puccetti C, McNamara R, O'Leary S, Corvin A, Gill M, Tropea D. Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study. Front Pediatr. 2014 Jun 03;2:52. doi: 10.3389/fped.2014.00052. eCollection 2014. PMID: 24918098; PMCID: PMC4042280.
Copy Download .nbib Format: NLM
Correction: Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection.

PLoS pathogens

Anderson CJ, Clark DE, Adli M, Kendall MM.
PMID: 26684793
PLoS Pathog. 2015 Dec 18;11(12):e1005365. doi: 10.1371/journal.ppat.1005365. eCollection 2015 Dec.

No abstract available.

Cite
Anderson CJ, Clark DE, Adli M, et al. Correction: Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection. PLoS Pathog. 2015;11(12):e1005365doi: 10.1371/journal.ppat.1005365.
Anderson, C. J., Clark, D. E., Adli, M., & Kendall, M. M. (2015). Correction: Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection. PLoS pathogens, 11(12), e1005365. https://doi.org/10.1371/journal.ppat.1005365
Anderson, Christopher J, et al. "Correction: Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection." PLoS pathogens vol. 11,12 (2015): e1005365. doi: https://doi.org/10.1371/journal.ppat.1005365
Anderson CJ, Clark DE, Adli M, Kendall MM. Correction: Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection. PLoS Pathog. 2015 Dec 18;11(12):e1005365. doi: 10.1371/journal.ppat.1005365. eCollection 2015 Dec. PMID: 26684793; PMCID: PMC4684284.
Copy Download .nbib Format: NLM
Selective recognition of fluoride salts by vasarenes: a key role of a self-assembled in situ dimeric entity via an exceptionally short [O-H-O](-) H-bond.

Dalton transactions (Cambridge, England : 2003)

Bengiat R, Gil M, Klein A, Bogoslavsky B, Cohen S, Dubnikova F, Yardeni G, Zilbermann I, Almog J.
PMID: 26804131
Dalton Trans. 2016 Jun 07;45(21):8734-9. doi: 10.1039/c5dt04171f. Epub 2016 Jan 25.

A self-assembled supramolecular dimeric entity via an exceptionally short (2.404 Å) and strong (22.9 kcal mol(-1)) [O-H-O](-) hydrogen bond is the key to the special reactivity of vasarenes with fluoride salts. Vasarene is a self-assembled, vase-shaped compound, obtained by...

Cite
Bengiat R, Gil M, Klein A, et al. Selective recognition of fluoride salts by vasarenes: a key role of a self-assembled in situ dimeric entity via an exceptionally short [O-H-O](-) H-bond. Dalton Trans. 2016;45(21):8734-9doi: 10.1039/c5dt04171f.
Bengiat, R., Gil, M., Klein, A., Bogoslavsky, B., Cohen, S., Dubnikova, F., Yardeni, G., Zilbermann, I., & Almog, J. (2016). Selective recognition of fluoride salts by vasarenes: a key role of a self-assembled in situ dimeric entity via an exceptionally short [O-H-O](-) H-bond. Dalton transactions (Cambridge, England : 2003), 45(21), 8734-9. https://doi.org/10.1039/c5dt04171f
Bengiat, R, et al. "Selective recognition of fluoride salts by vasarenes: a key role of a self-assembled in situ dimeric entity via an exceptionally short [O-H-O](-) H-bond." Dalton transactions (Cambridge, England : 2003) vol. 45,21 (2016): 8734-9. doi: https://doi.org/10.1039/c5dt04171f
Bengiat R, Gil M, Klein A, Bogoslavsky B, Cohen S, Dubnikova F, Yardeni G, Zilbermann I, Almog J. Selective recognition of fluoride salts by vasarenes: a key role of a self-assembled in situ dimeric entity via an exceptionally short [O-H-O](-) H-bond. Dalton Trans. 2016 Jun 07;45(21):8734-9. doi: 10.1039/c5dt04171f. Epub 2016 Jan 25. PMID: 26804131.
Copy Download .nbib Format: NLM
MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6.

Addiction biology

O'Donohoe A, O'Flynn K, Shields K, Hawi Z, Gill M.
PMID: 26734924
Addict Biol. 1998 Jul;3(3):309-14. doi: 10.1080/13556219872119.

3,4 Methylenedioxymethamphetamine (MDMA or ecstasy) has become a major drug of abuse over the last decade. It produces a mixture of systemic and neuropsychological effects. Animal studies show a range of short- and long-term toxic effects, both systemically and...

Cite
O'Donohoe A, O'Flynn K, Shields K, et al. MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6. Addict Biol. 1998;3(3):309-14doi: 10.1080/13556219872119.
O'Donohoe, A., O'Flynn, K., Shields, K., Hawi, Z., & Gill, M. (1998). MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6. Addiction biology, 3(3), 309-14. https://doi.org/10.1080/13556219872119
O'Donohoe, A, et al. "MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6." Addiction biology vol. 3,3 (1998): 309-14. doi: https://doi.org/10.1080/13556219872119
O'Donohoe A, O'Flynn K, Shields K, Hawi Z, Gill M. MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6. Addict Biol. 1998 Jul;3(3):309-14. doi: 10.1080/13556219872119. PMID: 26734924.
Copy Download .nbib Format: NLM
CONGENITAL ANOMALY PRESENTING AS LUMP ABDOMEN IN ADOLESCENT GIRL.

Medical journal, Armed Forces India

Harjai MM, Singh KJ, Gill M, Nagpal BM, Singh Y.
PMID: 27365581
Med J Armed Forces India. 2001 Jan;57(1):56-8. doi: 10.1016/S0377-1237(01)80094-0. Epub 2011 Jul 21.

No abstract available.

Cite
Harjai MM, Singh KJ, Gill M, et al. CONGENITAL ANOMALY PRESENTING AS LUMP ABDOMEN IN ADOLESCENT GIRL. Med J Armed Forces India. 2011;57(1):56-8doi: 10.1016/S0377-1237(01)80094-0.
Harjai, M. M., Singh, K. J., Gill, M., Nagpal, B. M., & Singh, Y. (2001). CONGENITAL ANOMALY PRESENTING AS LUMP ABDOMEN IN ADOLESCENT GIRL. Medical journal, Armed Forces India, 57(1), 56-8. https://doi.org/10.1016/S0377-1237(01)80094-0
Harjai, M M, et al. "CONGENITAL ANOMALY PRESENTING AS LUMP ABDOMEN IN ADOLESCENT GIRL." Medical journal, Armed Forces India vol. 57,1 (2001): 56-8. doi: https://doi.org/10.1016/S0377-1237(01)80094-0
Harjai MM, Singh KJ, Gill M, Nagpal BM, Singh Y. CONGENITAL ANOMALY PRESENTING AS LUMP ABDOMEN IN ADOLESCENT GIRL. Med J Armed Forces India. 2001 Jan;57(1):56-8. doi: 10.1016/S0377-1237(01)80094-0. Epub 2011 Jul 21. PMID: 27365581; PMCID: PMC4925031.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 608 entries